All ProductsDisplaying Products by Catalog Number (4900 - 4999)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800
| Cat. No. | Product Name / Activity |
|---|---|
| 4902 | NSC 405020 |
| Histone deacetylase inhibitor | |
| 4903 | NU 9056 |
| Inhibitor of KAT5 (Tip60) | |
| 4904 | UNC 1999 |
| Potent and selective EZH2/EZH1 inhibitor | |
| 4908 | GNF 5 |
| Selective allosteric inhibitor of Bcr-Abl; analog of GNF 2 (Cat. No. 4399) | |
| 4912 | GsMTx4 |
| TRPC1 and TRPC6 inhibitor; inhibits mechanosensitive ion channels | |
| 4913 | Jingzhaotoxin III |
| Selective NaV1.5 channel blocker | |
| 4914 | Phrixotoxin 3 |
| Potent blocker of NaV1.2, NaV1.3 and NaV1.5 channels | |
| 4916 | PF 04885614 |
| Potent and selective NaV1.8 channel blocker; active in vivo | |
| 4920 | Methoxy-X04 |
| Brain penetrant fluorescent amyloid β probe. Used for: detection and quantification of plaques, tangles and cerebrovascular amyloid. Application: confocal microscopy, suitable for in vivo imaging | |
| 4924 | CEP 1347 |
| Inhibitor of JNK signaling | |
| 4935 | Sulfasalazine |
| Inhibitor of NF-κB activation; also inhibits SXC and folate transporter 1 | |
| 4936 | Clozapine N-oxide |
| Activator of hM3Dq and hM4Di DREADDs | |
| 4941 | PKI 166 hydrochloride |
| Potent EGFR-kinase inhibitor | |
| 4942 | Pitavastatin calcium |
| HMG-CoA reductase inhibitor | |
| 4943 | Sulfidefluor 7 AM |
| H2S fluorescent probe | |
| 4944 | Peroxy Orange 1 |
| Fluorescent hydrogen peroxide indicator | |
| 4945 | ML 347 |
| Potent and selective ALK1 and ALK2 inhibitor | |
| 4946 | AIM 100 |
| Potent and selective Ack1 (TNK2) inhibitor | |
| 4948 | CYM 50769 |
| Novel non-peptide NPBWR1 antagonist | |
| 4949 | MaxiPost |
| Potassium channel modulator; exerts subtype-specific effects | |
| 4950 | ICA 110381 |
| KV7.2/7.3 activator; displays anticonvulsant properties | |
| 4951 | SA 4503 dihydrochloride |
| Selective σ1 receptor agonist | |
| 4953 | CHIR 99021 trihydrochloride |
| Hydrochloride salt of CHIR 99021 (Cat. No. 4423); selective GSK-3 inhibitor | |
| 4957 | ML 179 |
| Selective liver receptor homolog 1 (LRH1) inverse agonist | |
| 4958 | Eplivanserin hemifumarate |
| Potent and selective 5-HT2A antagonist | |
| 4959 | CID 16020046 |
| Selective GPR55 antagonist | |
| 4960 | AR-C155858 |
| MCT1 and MCT2 inhibitor; inhibits glycolysis in cancer cells | |
| 4961 | TC-S 7001 |
| Potent and highly selective ROCK inhibitor; orally active | |
| 4962 | SB 204990 |
| ATP citrate lyase (ACLY) inhibitor | |
| 4963 | SC 144 hydrochloride |
| gp130 inhibitor; blocks cytokine-triggered gp130 signaling | |
| 4968 | CCT 241533 dihydrochloride |
| Potent Chk2 inhibitor | |
| 4970 | BMS 688521 |
| Potent inhibitor of the LFA-1/ICAM interaction | |
| 4972 | JIB 04 |
| Pan Jumonji inhibitor; active in vivo | |
| 4975 | CRT 0066101 |
| Potent protein kinase D (PKD) inhibitor | |
| 4977 | RN 1 dihydrochloride |
| LSD1 inhibitor | |
| 4978 | Pyrintegrin |
| Enhances survival of human ESCs following enzymatic dissociation | |
| 4979 | Methylmalonate |
| Succinate dehydrogenase inhibitor | |
| 4982 | ML 337 |
| Selective negative allosteric modulator of mGlu3 receptors | |
| 4983 | ACT 335827 |
| Potent and selective OX1 antagonist | |
| 4986 | K 02288 |
| Type 1 BMP receptor inhibitor | |
| 4991 | HaXS8 |
| Chemical dimerizer | |
| 4992 | IWP L6 |
| Potent PORCN inhibitor | |
| 4993 | NSC 624206 |
| Ubiquitin-activating enzyme (E1) inhibitor | |
| 4995 | Phortress |
| Prodrug of the antitumor agent 5F 203 | |
| 4997 | INDY |
| DYRK1A/B inhibitor |